Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/1123
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sobirova D.R | - |
dc.contributor.author | Azizova F.X., Ishandjanova S.X., Otajanova A.N., Utepova N.B. | - |
dc.date.accessioned | 2021-12-27T09:02:02Z | - |
dc.date.available | 2021-12-27T09:02:02Z | - |
dc.date.issued | 2021-11-11 | - |
dc.identifier.issn | 2776-1010 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/1123 | - |
dc.description.abstract | The question of the need to prescribe antibiotic therapy to patients with exacerbation of chronic obstructive pulmonary disease requires justification of the prescription of an antibiotic, taking into account the likelihood of an etiological role of an infectious factor, the possibility of spontaneous remissions, as well as the risk of negative consequences in case of unreasonable prescription (development of microorganism resistance, unwanted side effects, unjustified costs) ... In addition, the large arsenal of modern antibiotics poses the problem of choosing the optimal drug for the doctor. With extreme caution, it is necessary to treat the choice of antibiotic therapy for patients with diabetes mellitus with concomitant chronic obstructive pulmonary disease. | en_US |
dc.language.iso | en | en_US |
dc.subject | chronic obstructive pulmonary disease, diabetes mellitus, diabetic microangiopathy, microcirculation, lung tissue. | en_US |
dc.title | «Study of changes in pulmonary alveolar epithelium and aerogematic barrier in diabetes mellitus» | en_US |
dc.type | Article | en_US |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
433-Article Text-813-1-10-20211117_compressed (1).pdf | 108.92 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.